ClinicalTrials.gg
CompletedNCT06859606Updated Mar 5, 2025

Mandibular Sequential Distalization Versus Class III Elastics With Clear Aligners in Class III Patients

An interventional study of Lower molar distalization and Class III elastics in Class III Malocclusion, sponsored by Saint Camillus International University of Health Sciences. Completed at 1 site in Italy. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2025-03-05.

Sponsored by Saint Camillus International University of Health Sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Dec 2022, registered Feb 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

Distalizing mandibular molars may be indicated for patients with minor skeletal Class III discrepancies or in Class III subjects with mild crowding. Traditionally, mandibular molar distalization was accomplished using elastics, open coils, and the multiloop edgewise archwire technique. In recent years, several techniques have been developed to reduce the dependence on patient compliance, such as skeletal anchorage. Recently, several reports have been published on mandibular distal movement using miniscrews and some case reports have shown the possibility of obtaining Class III correction with sequential mandibular distalization in non-growing subjects by means of clear aligners. However, a sound clinical judgment should always be made on the basis of a higher level of evidence. Therefore, the purpose of the present prospective study is to provide a detailed analysis of the underlying skeletal and dental changes determined by mandibular distalization therapy with the sequential Invisalign protocol in permanent dentition. This will be accomplished by testing the following null hypothesis: mandibular molar distalization is not achievable with aligners without the application of TADs.

Read the detailed description

Class III malocclusion is considered one of the most challenging maxillofacial disorders in clinical practice characterized by an antero-posterior discrepancy with mandibular protrusion, maxillary retrusion, or a combination of both. In adult patients, managing this condition is further complicated by the absence of residual skeletal growth, limiting therapeutic options to orthodontic interventions and, in some cases, surgical procedures. Diagnosis in Class III adult patients requires distinguishing between skeletal malocclusion and dento-alveolar discrepancy. The combination of orthognathic surgery and orthodontic therapy represents the gold standard for more severe skeletal Class III disharmonies, leading to an improvement of both function and aesthetics. On the other hand, in Class III cases characterized by a prevalent dental component or mild skeletal discrepancy, the malocclusion can be addressed with a dento-alveolar compensation. In these cases, the clinical objectives are to achieve a correct sagittal, canine and molar Class I relationship, as well as ideal values of overjet and overbite. The non-surgical orthopedic approach involves the application of Class III elastics or the distalization of the lower molars, which can improve the sagittal occlusal relationship. As a matter of fact, mandibular distalization allows the increase of lower arch length along with the achievement of the necessary space to correct a Class III relationship. However, bone density and root anatomy make lower molar distalization difficult to achieve. In addition, one of the most frequent adverse effects is represented by the anterior anchorage loss with a worsening of lower incisor proclination and overjet values. Traditional appliances feature the use of open coil springs, inter arch elastics, and lip bumper device combined with fixed appliances. Nowadays, the development of clear aligner technology provides new opportunities even in the management of complex malocclusion cases, including Class III discrepancies. In particular, molar distalization movements and intermaxillary elastics have been proposed as a valid clinical strategy to improve the occlusal relationship without requiring skeletal anchorage devices. During the sagittal mechanics, over-corrected movements should be planned in order to obtain more bodily movements of the lower molars. Moreover, the best accuracy and predictability of distalization movements are supported by the sequential staging and the presence of attachments on the tooth surfaces. Nowadays, scientific evidence on this topic is limited and it is influenced by restrictions in terms of sample size, retrospective design, and lack of long-term observation. Hence, the aim of the present study was to evaluate the efficacy and efficiency of intermaxillary elastics combined with lower molar distalization by means of clear aligners in the treatment of Class III malocclusion in adult patients. More specifically, a randomized controlled trial (RCT) was conducted to evaluate the antero-posterior correction induced by Class III elastics combined with lower distalization movements and the application of Class III elastics alone. The possibility of achieving satisfying clinical outcomes without the use of skeletal anchorage was considered to avoid an invasive orthodontic approach

02

Conditions studied

  • Class III Malocclusion

Keywords

  • class III malocclusion
  • lower molar distalization
  • class III elastics
  • clear aligner treatment
03

In context

Malocclusion, Angle Class III

57 studies on the registry are indexed under Malocclusion, Angle Class III; 11 are open to participants now.

This study's enrollment of 30 is close to the median of 32 across 53 interventional studies indexed under Malocclusion, Angle Class III.

Browse Malocclusion, Angle Class III studies →

Lead sponsor

Saint Camillus International University of Health Sciences is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult age (≥19 years)
  • permanent dentition including second permanent molars
  • skeletal Class I or slight Class III (-2° \< ANB \< +2°)
  • normal skeletal divergency pattern (SN\^GoGn, 27°-37°)
  • Class III canine and molar relationship at baseline (T0), moderate lower arch crowding (≤ +4 mm)
  • good compliance with aligners and elastics (≥ 20 hours/day)

Exclusion criteria

Exclusion Criteria:

  • severe skeletal Class III malocclusion (ANB \< -2°)
  • transversal maxillary deficiency
  • use of Temporary Anchorage Devices (TADs)
  • extraction treatments other than third molars
  • periodontal disease or temporomandibular disorders (TMDs).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Group 1 - Lower Distalization Protocol

    In Group 1 (Lower Distalization Protocol), all subjects underwent lower molar distalization combined with Class III elastics.

    Other: Lower molar distalization

  • Experimental
    Group 2, Non-Distalization Protocol

    In Group 2 (Non-Distalization Protocol) all subjects were treated with dento-alveolar expansion and Class III elastics

    Other: Class III elastics

Interventions

  • OtherLower molar distalization

    Lower Distalization Protocol included extraction of the lower third molars before starting treatment and a 50% sequential lower distalization with two teeth being distalized at a time. The distalization started with the movement of lower second molars, followed by the first molars halfway through the process, and so on. Once the canine reached the right position, the "en masse" retraction of the four incisors completed the treatment plan. The protocol comprised the use of Class III intermaxillary elastics to support the distalization movement and to control the proclination of lower incisors

  • OtherClass III elastics

    Non-Distalization Protocol featured extraction of the lower third molars before starting treatment, transversal dento-alveolar coordination, strategic interproximal reduction (IPR) in the anterior segment of the lower arch, and the addition of Class III elastics

06

What researchers measure

Primary outcomes

  1. Lower molar positional changes expressed by means of linear and angular measurements (L6-MP mm; L6-MP angle; L6 - CoGo mm; L6 apex - CoGo mm)

    L6-MP mm: linear distance between the mesial cusp of lower first molar and Mandibular plane L6-MP angle: angle between long axis of lower first molar and Mandibular plane L6 - CoGo mm: linear distance between the mesial cusp of lower first molar and CoGo line L6 apex - CoGo mm: linear distance between the apex of lower first molar and CoGo line

    Time frame: from the start of treatment to the end at 24 months

Secondary outcomes

  1. Changes in inclination of the lower incisors (IMPA angle)

    IMPA angle: angle between long axis of the lower incisor and mandibular plane

    Time frame: from the start of treatment to the and at 24 months

  2. Changes in position of the lower incisors (L1-CoGo mm; L1apex - CoGo)

    L1-CoGo mm: linear distance between the tip crown of the lower incisor L1apex - CoGo mm: linear distance between the apex of the lower incisor and CoGo line

    Time frame: from the start of treatment to the and at 24 months

  3. Sagittal skeletal changes (SNA angle, SNB angle, ANB angle)

    SNA angle: maxillary sagittal position SNB angle: mandibular sagittal position ANB angle: maxillomandibular sagittal discrepancy

    Time frame: from start of treatment to to the end at 24 months

  4. Sagittal skeletal changes (Wits appraisal)

    Wits appraisal: maxillomandibular sagittal discrepancy

    Time frame: from start of treatment to to the end at 24 months

  5. Vertical skeletal changes (SN^MP angle, Gonial Angle)

    SN-MP angle between Sella/Nasion plane and Mandibular plane Gonial angle, angle between Ar-Go plane and Go-Me plane

    Time frame: from the start of treatment to the end at 24 months

  6. Changes of upper incisors inclination

    Incisor inclintion: angle between long axis of upper incisor and Sella Nasion

    Time frame: from the start of treatment to the and at 24 months

  7. Overbite and Overjet values

    Overbite mm: horizontal distance between the upper and lower incisors on the occlusal plane Overjet mm: vertical distance between the upper and lower incisors on the occlusal plane

    Time frame: from the start of treatment to the and at 24 months

07

Study locations

1 site
  • Saint Camillus International University of Health Sciences
    Rome, 00131, Italy
08

References and documents

Publications

  • Martina H, Stefano Adriana A, Ernesto B, Alessandra I, Roberto AV, Gabriella G. Lower molar distalization using clear aligners: Is it effective? A systematic review. J Orthod Sci. 2024 Feb 16;13:11. doi: 10.4103/jos.jos_174_23. eCollection 2024. PubMed 38516119 ↗
  • Rota E, Parrini S, Malekian K, Cugliari G, Mampieri G, Deregibus A, Castroflorio T. Lower molar distalization using clear aligners: bodily movement or uprighting? A preliminary study. Appl. Sci. 2022, 12(14), 7123.
  • Han J, Ning N, Du H, Zhou M, Cai C, Hong Y, et al. Efficacy of clear aligners on mandibular molar distalization: A retrospective study. Digit Med 2021; 7:1.
  • Padmanabhan A, Khan Y, Lambate V, K U, Naveed N, Singh M, Nagi PK. Efficacy of Clear Aligners in Treating Class III Malocclusion With Mandibular Molar Distalization: A Systematic Review. Cureus. 2023 Nov 1;15(11):e48134. doi: 10.7759/cureus.48134. eCollection 2023 Nov. PubMed 38046776 ↗
  • Pavoni C, Gazzani F, Franchi L, Loberto S, Lione R, Cozza P. Soft tissue facial profile in Class III malocclusion: long-term post-pubertal effects produced by the Face Mask Protocol. Eur J Orthod. 2019 Sep 21;41(5):531-536. doi: 10.1093/ejo/cjz003. PubMed 30865768 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2022 to primary completion in Dec 2024, 24 months.

Of 37 non-industry interventional studies with no phase under Malocclusion, Angle Class III, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 26. This study's 24 months is above that.

Counting every sponsor, half of 38 studies reached it within 13 months; a quarter within 10 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 11, 2025
First posted
Mar 5, 2025
StartActual
Dec 1, 2022
Primary completionActual
Dec 1, 2024
CompletionActual
Jan 10, 2025
Last update
Mar 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06859606
Lead sponsor
Saint Camillus International University of Health Sciences
Responsible party
Francesca Gazzani (Research Assistant, Saint Camillus International University of Health Sciences) — Principal investigator
First posted
Mar 5, 2025
Start date
Dec 1, 2022
Primary completion
Dec 1, 2024
Completion
Jan 10, 2025
Last update
Mar 5, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion